Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Advicenne
company
About
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.
- 1 - 10
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- €5M
- Industries
- Biotechnology,Medical,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€21M $7.50M
Advicenne has raised a total of
€21M $7.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 5, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 5, 2022 | Post-IPO Debt | €5M | 1 |
European Investment Bank
|
— | Detail |
| Aug 11, 2020 | Post-IPO Debt | $7.50M | 1 |
European Investment Bank
|
— | Detail |
| Mar 20, 2017 | Series Unknown | €16M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Advicenne is funded by 2 investors.
European Investment Bank
and InnoBio Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Post-IPO Debt |
InnoBio Fund
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
